CO-ADTRAN
30.4.2024 14:01:32 CEST | Business Wire | Press release
Adtran today announced that Commnet Broadband is leveraging Intellifi® as part of its Mosaic One software-as-a-service (SaaS) solution to enhance in-home connectivity as the service provider scales across the American Southwest. The cloud-managed Wi-Fi solution will enable Commnet Broadband to deliver a seamless, always-on mesh Wi-Fi experience, boosting subscriber satisfaction while driving new efficiencies. With a strong commitment to digital inclusion, Commnet Broadband is extending its reach into more underserved rural communities, connecting them with reliable and high-quality internet services. Deploying Mosaic One for remote service activation and troubleshooting, along with Intellifi® for AI-driven insights and complete control over the home Wi-Fi environment, enables the company to efficiently manage its expansive and diverse network infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430732731/en/
Adtran’s Mosaic One and Intellifi® are helping Commnet deliver robust Wi-Fi services to underserved communities. (Photo: Business Wire)
“At Commnet Broadband, our mission is to empower underserved regions of America through reliable and personalized internet access. With Adtran’s Intellifi® solution, we’re taking our service delivery capabilities to the next level, ensuring uninterrupted and hassle-free Wi-Fi for both fiber and fixed wireless customers across our footprint,” said Scott Horne, CEO of Commnet Broadband. “One key advantage of our new system is the enhanced visibility it offers into customer premises, reducing the need for tier 1 tech support and minimizing truck rolls. Features like network-wide speed tests will enable us to analyze detailed heat maps, revealing our network’s strengths and pinpointing areas for improvement. This clear understanding of latency and speed capabilities will help us uplift the most isolated communities, ensuring we make a real and impactful difference.”
Adtran’s Intellifi®, part of the Mosaic One suite, provides a robust, cloud-hosted portal that transforms home Wi-Fi management for Commnet Broadband’s subscribers. It enhances customer support with features like Intellifi® MeshView, an operator portal that facilitates automated issue detection and remote resolution. The Intellifi® mobile app supports subscriber self-installs and offers comprehensive network control, including parental settings and device management. Mosaic One equips network engineers with predictive tools that monitor network access and identify at-risk connections. This proactive approach not only helps preemptively address issues, thereby reducing the need for on-site repairs, but it also enhances network reliability and subscriber uptime. Adtran’s Wi-Fi 6 service delivery gateways (SDGs) and mesh satellites also help ensure an exceptional Wi-Fi experience for subscribers.
“We’re excited to support Commnet Broadband as they expand their reach into more digitally excluded areas and elevate their services for all subscribers. With our Mosaic One and Intellifi® solutions, they can harness the full potential of managed Wi-Fi. That means delivering true Gigabit and multigigabit speeds and a superior level of service,” commented John Scherzinger, GM of Americas sales at Adtran. “The comprehensive telemetry, insights and user experience data that Intellifi® provides will empower Commnet Broadband to tailor services more precisely to each customer’s needs. Our virtual field technician feature can also cut operational costs, generating substantial savings per truck roll. Moreover, our technology creates new revenue opportunities, enabling Commnet Broadband to offer differentiated services that cater to the specific needs of communities, businesses and families.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
About Commnet Broadband
Commnet Broadband, wholly owned subsidiary of ATN International, Inc. (NASDAQ: ATNI), provides high-quality broadband communications services to carrier customers in rural America and Tribal communities, driving digital inclusion and providing access to education, work, healthcare, safety, entertainment, and community connectivity. Learn more at www.commnetbroadband.com.
Published by
ADTRAN Holdings, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240430732731/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom